As usual, awesome list trding! I would suggest
Post# of 148286
I would suggest to add:
Science Advisors: Dr. Dennis Burger to Science Advisors for his role in GvHD and MS. I am not sure if he is officially a Science Advisor or where that list is available, but he is definitely involved in these two indications. I don't recall the local university he is working with for the MS P2 protocol?
Potential benefits: ZERO Serious Adverse Events in over 850 patients.
HIV: Fast Track Designation, Rolling Review for BLA
Mono: 5 patients on mono for over 4 years; over 100 patients on mono for over 1 year (I don't recall the exact number and dates, but feel this is an important fact to note).
TNBC: Patient 1 CTC reduced to zero in only 8 weeks of treatment.
GvHD: Orphan Drug Designation
Maybe a note about other potential CCR5 indications: MS, COPD, Alzheimer's Disease, Atherosclerosis, Diabetes, HCV, Inflammatory Bowel, Pulmonary Diseases, Rabies, Stroke, TB, etc. with links to the research articles yourself and ohm shared?